NADIA BERRO: Open Payments
NPI 1750983144 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 53 payments from 18 companies in 2025. Trend: 2023 $48 · 2024 $1,803 · 2025 $1,478
Food & beverage: $1,478
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $391 |
| Novo Nordisk Inc | 7 | $174 |
| Merck Sharp & Dohme LLC | 7 | $161 |
| BridgeBio Pharma, Inc. | 4 | $139 |
| Esperion Therapeutics, Inc. | 5 | $88 |
| PFIZER INC. | 4 | $82 |
| Alnylam Pharmaceuticals Inc. | 2 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| Tactile Systems Technology Inc | 1 | $48 |
| SCPHARMACEUTICALS INC. | 2 | $43 |
Products named: LifeVest, Wegovy, VERQUVO, Attruby, NEXLETOL, VYNDAQEL, AMVUTTRA, LEQVIO.
Industry payments across MI — which companies pay providers there.
